Medicare Enrolled

Dr. Mitul Patel, DO

Cardiovascular Disease · Hudson, FL
Low-engagement
14100 FIVAY RD STE 310, Hudson, FL 34667
7274715882
In practice since 2017 (8 years)
NPI: 1689104341 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Mitul Patel is a cardiovascular disease in Hudson, FL, with 8 years in practice.

Between the years covered by Open Payments, Dr. Patel received a total of $13,063 from 22 pharmaceutical and/or device companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice$ $13,063 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,063
Total received (2018-2024)
Avg $1,866/year across 7 years
Top 20% in FL for cardiovascular disease
22
Companies
171
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,593 (81.1%)
Scientific / Research
Research funding and grants
$2,470 (18.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,609
2023
$3,802
2022
$1,538
2021
$1,415
2020
$302
2019
$175
2018
$222

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$2,932
Medtronic, Inc.
$1,883
Edwards Lifesciences Corporation
$1,819
Abbott Laboratories
$1,776
Inari Medical, Inc.
$814
Penumbra, Inc.
$782
Cardiovascular Systems Inc.
$508
ABIOMED
$464
BOSTON SCIENTIFIC CORPORATION
$460
Terumo Medical Corporation
$404
E.R. Squibb & Sons, L.L.C.
$211
PFIZER INC.
$167
ShockWave Medical, Inc
$163
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$148
CARDIVA MEDICAL, INC.
$128
AstraZeneca Pharmaceuticals LP
$124
EKOS Corporation
$96
ABBVIE INC.
$50
Kestra Medical Technology Services, Inc.
$43
Recor Medical Inc
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
UCB, Inc.
$15
Top 3 companies account for 50.8% of total payments
Associated products mentioned in payments ›
ACCOLADE SR · ANGIO-SEAL · ASSURITY · AVEIR · AVVIGO Guidance System · AZURE XT DR MRI SURESCAN · Assure WCD · Azure · CAMZYOS · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · COROFLOW · Cimzia · Claria MRI · Cobalt · Confirm Rx · CoreValve Evolut · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · Diamondback Coronary · Diamondback Peripheral · Dragonfly OCT · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EKOSONIC · ELIQUIS · ENDURANT IIS · EUCRISA · FARXIGA · FEMOSTOP · FLOWTRIEVER CATHETER · FORTIFY ASSURA · GALLANT · GENERAL BRADY · GENERAL STENTS · GENERAL THERAPIES · GENERAL - THERAPIES · GLIDESHEATH SLENDER · GLIDEWIRE · General - Ultrasound · HELI-FX ENDOANCHOR SYSTEM · Impella · Indigo System · JETI PERIPHERAL CATHETER · JOT DX · JUDO 6 · LATITUDE Communicator Power Supply · LINQ II · LifeVest · MICRA · MITRACLIP · Micra · MitraClip System · NAVITOR · OFEV · ONYX FRONTIER · PARADISE RENAL DENERVATION SYSTEM · PERCLOSE PROGLIDE · PERCLOSE PROSTYLE · Perclose ProStyle · Polaris Ultra · R2P MISAGO · ROTAPRO · RUBY Coil · S · SAPIEN 3 Ultra RESILIA · STIOLTO RESPIMAT · SUPERA · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TYRX · VYNDAQEL · WATCHMAN · WATCHMAN Access System · XIENCE SIERRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease in Hudson?
Compare cardiovascular diseases in the Hudson area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
63
Per 100K population
10.7
County median income
$67,384
Nearest hospital
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a cardiovascular disease, and high industry engagement (low-engagement, top 20%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $13,063 from 22 companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →